About: Minretumomab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Minretumomab (CC49) is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen. This includes breast, colon, lung, and pancreatic cancers. Apparently, it never got past Phase I clinical trials for this purpose.

Property	Value
dbo:abstract	مينريتوموماب هو جسم مضاد وحيد النسيلة فأري مصمم لعلاج السرطان. (ar) Minretumomab (CC49) is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen. This includes breast, colon, lung, and pancreatic cancers. Apparently, it never got past Phase I clinical trials for this purpose. (en)
dbo:atcCode	(125Iradiolabelled)
dbo:casNumber	195189-17-4
dbo:fdaUniiCode	235435CH6L
dbo:wikiPageID	9703424 (xsd:integer)
dbo:wikiPageLength	5036 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	984396824 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cancer dbr:Mouse dbr:Beta-lactamase dbr:Breast_cancer dbr:CA_72-4 dbr:Iodine-131 dbr:Monoclonal_antibody dbr:TAG-72 dbr:Lung_cancer dbr:Clinical_trials dbr:Fusion_protein dbr:Radioimmunoassay dbr:Iodine-125 dbc:Monoclonal_antibodies_for_tumors dbr:Lutetium-177 dbr:Human_anti-mouse_antibodies dbr:Single-chain_variable_fragment dbr:Colon_cancer dbr:Pancreas_cancer dbr:Tumour dbr:Phase_I_clinical_trial dbr:Radiolabelled
dbp:atcPrefix	V09 (en)
dbp:atcSuffix	IX03 (en)
dbp:atcSupplemental	(en)
dbp:casNumber	195189 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:mabType	mab (en)
dbp:source	o (en)
dbp:synonyms	CC49 (en)
dbp:target	dbr:TAG-72
dbp:type	mab (en)
dbp:unii	235435 (xsd:integer)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	458284190 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Monoclonals_for_tumors
dcterms:subject	dbc:Monoclonal_antibodies_for_tumors
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:WikicatMonoclonalAntibodiesForTumors yago:WikicatUnnamedMonoclonalAntibodies yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459 umbel-rc:DrugProduct
rdfs:comment	مينريتوموماب هو جسم مضاد وحيد النسيلة فأري مصمم لعلاج السرطان. (ar) Minretumomab (CC49) is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen. This includes breast, colon, lung, and pancreatic cancers. Apparently, it never got past Phase I clinical trials for this purpose. (en)
rdfs:label	مينريتوموماب (ar) Minretumomab (en)
owl:sameAs	freebase:Minretumomab freebase:Minretumomab yago-res:Minretumomab wikidata:Minretumomab dbpedia-ar:Minretumomab dbpedia-vi:Minretumomab https://global.dbpedia.org/id/4sBH4
prov:wasDerivedFrom	wikipedia-en:Minretumomab?oldid=984396824&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Minretumomab
is dbo:wikiPageRedirects of	dbr:Iodine_(125I)_CC49 dbr:Iodine_(125I)_minretumomab dbr:ATC_code_V09IX03 dbr:ATCvet_code_QV09IX03 dbr:Iodine_(125I)_CC49-monoclonal_antibody dbr:CC-49 dbr:CC49
is dbo:wikiPageWikiLink of	dbr:Iodine_(125I)_CC49 dbr:Iodine_(125I)_minretumomab dbr:Tumor-associated_glycoprotein_72 dbr:ATC_code_V09IX03 dbr:ATCvet_code_QV09IX03 dbr:List_of_therapeutic_monoclonal_antibodies dbr:Iodine_(125I)_CC49-monoclonal_antibody dbr:List_of_drugs:_Meu–Mi dbr:CC-49 dbr:CC49
is foaf:primaryTopic of	wikipedia-en:Minretumomab